Conservative management in a case of retained adherent placenta in a primigravida patient

Annal Abhay Vaidya; Shruti Panchbudhe; Meena Satia

doi:10.18203/2320-1770.ijrcog20172962

Authors

Annal Abhay Vaidya Department of Obstetrics and Gynecology, G. S. Medical College and King Edward Memorial Hospital, Mumbai, Maharashtra, India
Shruti Panchbudhe Department of Obstetrics and Gynecology, G. S. Medical College and King Edward Memorial Hospital, Mumbai, Maharashtra, India
Meena Satia Department of Obstetrics and Gynecology, G. S. Medical College and King Edward Memorial Hospital, Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20172962

Keywords:

Adherent placenta, Conservative management, Methotrexate

Abstract

Morbidly adherent placenta is a serious and a catastrophic pregnancy complication. In this condition, the placenta penetrates deeply inside the uterine walls and is not separated after delivery of the baby. Reporting herewith a case of a primigravida who had undergone Emergency lower segment Caesarean section at a private hospital for severe pregnancy induced hypertension with IUGR and then was referred to Tertiary Care hospital with placenta left in-situ due to non-separation of the placenta at the time of caesarean section. Conservative management was given using Methotrexate which is an anti-metabolite alternatively with Leucovorin (Folinic acid) and followed up with serial ultrasonography with Doppler for placental size and volume and beta-HCG levels which showed a decreasing trend respectively.

Metrics

Metrics Loading ...

References

Chandraharan E, Rao S, Belli AM, Arulkumaran S. The Triple-P procedure as a conservative surgical alternative to peripartum hysterectomy for placenta percreta. Int J Gynaecol Obstet. 2012;117(2):191-4.

Konijeti R, Rajfer J and Askari A. Placenta Percreta and the Urologist. Rev Urol. 2009;11(3):173-6.

Wu S, Kocherginsky M, Hibbard JU, Abnormal placentation twenty-year analysis. Am J Obstet Gynecol. 2005;192(5):1458-61.

Hung TH, Shau WY, Hsieh CC, Chiu TH, Hsu JJ, Hsieh TT. Risk factors for placenta accrete. Obstetr Gynecol. 1999;93(4):545-50.

Jacques SM, Qureshi F, Trent VS, Ramirez NC. Placenta accreta Mild cases diagnosed by placental examination. Int J Gynecol Pathol. 1996;15:28-33.

Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa–placenta accreta. Am J Obstetr Gynecol. 1997;177(1):210-4.

Flood KM, Said S, Geary M, Robson M, Fitzpatrick C, Malone FD. Changing trends in peripartum hysterectomy over the last 4 decades. Am J Obstet Gynecol. 2009;200(6):632e1-6

Hudon L, Belfort MA, Broome DR. Diagnosis and management of placenta percreta: a review. Obstet Gynecol Surv. 1998;53(8):509-17.

Comstock CH. Antenatal diagnosis of placenta accreta: a review. Ultrasound in Obstetrics and Gynecology. 2005;26(1):89-96.

Comstock CH, Love JJ, Bronsteen RA, Lee W, Vettraino IM, Huang RR. Sonographic detection of placenta accreta in the second and third trimesters of pregnancy. Am J Obstet Gynecol. 2004;190:1135-40.

ACOG Committee on Obstetric Practice Committee opinion no. 266: placenta accreta. Obstet Gynecol. 2002;99:169-70.

Eller AG, Bennett MA, Sharshiner M, Masheter C, Soisson AP, Dodson M, et al. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol. 2011;117:331-7.

Arnadottir BT, Hardardóttir H, Marvinsdóttir B. Case report seventeen year old primipara with placenta increta treated with methotrexate. Laeknabladid. 2008;94(7-8):549-52.

Kinoshita T, Ogawa K, Yasumizu T, Kato J. Spontaneous rupture of the uterus due to placenta percreta at 25-weeks of gestation: a case report. J Obstetr Gynecol Res. 1996;22(2):125-8.

Rajkumar B, Kumar N, Srinivasan S. Placenta percreta in primigravida, an unsuspected situation. Int J Reproduct Contracept Obstet Gynecol. 2016;3(1):239-41.